Option chain shows key data for Mirage Energy's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mirage Energy.

Mirage Energy (OTC:MRGE) Stock, Option Chain

Merge Healthcare Incorporated.

Mirage Energy Corp develops an integrated natural gas transportation and storage facility in Mexico and the United States. The natural gas will be exported from the United States by pipeline to the Mexican storage unit for later distribution throughout Mexico.

Merge Healthcare

News

Intraday Update

Markets

Movers

Trading Ideas

ACGL

ACLS

ACRE

AGNC

AJRD

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLT

ALLVF

ALNY

ALPMY

ALSK

AMED

APAM

AQUA

ARES

ARMZF

ASHTF

ASHTY

ASML

ASND

ASPU

ASTE

BAYZF

BCPC

BXMT

CBRE

CBSH

CCMP

CCOI

CCXI

CGEN

CIFAF

CLBK

CLPBY

CSLLY

CTAS

CTVEF

CWEN

CWEN-A

DKILY

DOOO

DQJCY

DSDVY

DSNKY

ENPH

EONGY

EPRT

Eaton Vance Tax-Advantaged Global Dividend

EXLS

FAST

FBHS

FCPT

FELE

Flaherty Crumrine/Claymore Preferred Securities

Stocks That Hit 52-Week Highs On Thursday

AAXN

ABLZF

ACDSF

ADBE

ADCOF

ADNT

ADSK

ADYEY

AIQUY

ALEC

ALFVY

ALLE

AMRC

AMZN

ANSS

APPF

BESIY

BFAM

BFST

BKOR

BMRMF

BROG

BTAI

BTDPY

CCLAY

CCOEY

CDAY

CERN

CHDN

CLPBF

CNSWF

CPRT

CSGP

DDOG

DOCU

DPDW

DSGX

ENAKF

ENBP

EPAM

Stocks That Hit 52-Week Highs On Wednesday

MRGE

PLAB

STRM

Photronics, Kronos Worldwide, OmniComm Systems, Streamline Health Solutions and Merge Healthcare highlighted as Zacks Bull and Bear of the Day

MIRAGE ENERGY CORP by Mirage Energy Corporation

Mirage Energy Corp

Contracts

Merge Healthcare  Inc, ifa Systems AG To Partner To Provide Ophthalmic Imaging Solutions

Merge Healthcare Incorporated (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>), a leading provider of clinical systems and innovations that seek to transform healthcare, entered into an agreement to provide its Merge Hemo™ solution to Baptist Health System of Birmingham, Alabama.
Baptist Health System was seeking a technology solution that would streamline its workflows and monitor patients throughout their entire cardiac procedure. Using Merge Hemo™, the cardiology teams at Princeton Baptist Medical Center, Shelby Baptist Medical Center and Walker Baptist Medical Center will be able to leverage a centralized, web-based system for report generation and distribution.
"We are excited to improve patient safety and coordination of care as well as enhance our clinician's experience by partnering with Merge," said Dr. Chris Davis, ‎chief information officer and chief medical informatics officer at Baptist Health System. "Integrating the hemodynamic procedural documentation directly into Epic (HIS) reduces duplicative documentation, and also makes it immediately available to other clinicians. Workflow will be further streamlined through patient scheduling and integrated lab results."
"Baptist Health System and its cardiologists want to simplify their workflow in order to free up time to dedicate to patient care and enhanced outcomes," said Justin Dearborn, chief executive officer of Merge Healthcare.

Press Releases

Baptist Health System Selects Merge Healthcare to Further Enhance Cardiology Care

International Business Machines Corp. (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) has long provided hospitals and medical centers with computers and operating systems that help track patient data, organize information and help smooth out the chaotic daily operations healthcare professionals face.

	However, the company appears to be <a href="http://www.wsj.com/articles/ibm-crafts-a-role-for-artificial-intelligence-in-medicine-1439265840">expanding its role in the healthcare space</a> in order to solve medical problems as well as operational ones.

	IBM is planning to acquire Merge Healthcare Inc (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>), a medical image storage company, in a deal which will allow IBM to extend its reach a bit further.
<h3>
	Artificial Intelligence</h3>

	IBM is planning to use Merge&#39;s massive database of X-ray, MRI and other images to create a system that will aid doctors in diagnosing patients quickly and correctly.

	In order to do this, IBM will use deep learning, a technique used to power things like voice recognition and fraud detection. Computers are given a huge amount of data to sort, and by doing that the machine is able to learn patterns and use them for future detection. IBM believes that this type of system would allow its computers to detect things like tumors or heart disease.

	<bzrelatedlink>Related Link: <a href="http://www.benzinga.com/news/15/08/5750195/an-industry-you-probably-didnt-know-is-digitized-agriculture">An Industry You Probably Didn&#39;t Know Was Digitized: Agriculture</a></bzrelatedlink>
<h3>
	Risks</h3>

	While the idea is promising, IBM will face a lot of hurdles in the development process. As medical data is often complex and each case can differ widely, artificial intelligence may struggle to correctly identify patterns.

	However, many believe that IBM&#39;s access to medical data in combination with Merge&#39;s images could give the company enough information to discover new diagnosis patterns that were previously unseen.

	Still, the prospect of using machines for diagnosis is still far in the future. Most believe that IBM&#39;s new system will become a companion or supplementary tool for doctors.

Health Care

Tech

General

IBM To Change Its Role In Healthcare

A new report by J.P. Morgan analyst Tien-tsin Huang focuses on the IT Services industry, particularly its relationship with the Healthcare sector. Huang addressed recent developments and trends in the industry and the impact they could have on the major players.
<h3>
	IBM Acquires Merge</h3>

	Last week, International Business Machines Corp (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) agreed to purchase Merge Healthcare Inc (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) and its medical image handling and processing platform for $1 billion.

	&ldquo;IBM intends to integrate Merge&rsquo;s medical imaging management platform with Watson&rsquo;s newly developed image analytics capabilities to generate insights from medical images, electronic health records, wearable device data, and other related medical data,&rdquo; Huang explains, adding that he believes the deal &ldquo;makes sense&rdquo; when it comes to IBM&rsquo;s business strategy.
<h3>
	Growing Cloud</h3>

	According to the report, investors should expect a near-term pickup in outsourcing within the consumer durables, oil and gas, insurance, banking and utilities businesses. In addition, the rise of cloud services technology could drive down outsourcing prices and cap both overall spending and contract value.

	Research firm IDC is projecting that global cloud services spending will reach $70 billion in 2015 with manufacturing, banking, professional services and retail making up about half of the market.
<h3>
	Outlook</h3>

	Huang notes that Exlservice Holdings Inc (NASDAQ: <a class="ticker" href="/stock/exls#NASDAQ">EXLS</a>), WNS Ltd (NYSE: <a class="ticker" href="/stock/wns#NYSE">WNS</a>), Cognizant Technology Solutions Corp (NASDAQ: <a class="ticker" href="/stock/ctsh#NASDAQ">CTSH</a>) and Infosys Ltd (NYSE: <a class="ticker" href="/stock/infy#NYSE">INFY</a>) have reportedly been focusing on targeting business process outsourcing (BPO) deals with India-based and global healthcare providers.

	The table below shows the account exposure of major service providers to leading life sciences firms, including Johnson &amp; Johnson (NYSE: <a class="ticker" href="/stock/jnj#NYSE">JNJ</a>), Pfizer Inc (NYSE: <a class="ticker" href="/stock/pfe#NYSE">PFE</a>) and Merck &amp; Co Inc (NYSE: <a class="ticker" href="/stock/mrk#NYSE">MRK</a>).

	<img alt="ithealthcare.png" height="702" src="https://www.benzinga.com/files/images/2015/August/10/ithealthcare.png" width="994" />

Analyst Color

Biotech

Long Ideas

Analyst Ratings

CTSH

INFY

Here's Which IT Stocks Benefit From Healthcare M&A

Baird downgrades Merge Healthcare (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) from Outperform to Neutral.-market sources.

Downgrades

Baird Downgrades Merge Healthcare to Neutral

Topeka Capital downgrades Merge Healthcare (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) from Buy to Hold.-market sources.

Topeka Capital Downgrades Merge Healthcare to Hold

The following are the M&amp;A deals, rumors and chatter circulating on Wall Street for Thursday August 4, 2015:
IBM to Acquire Merge Healthcare for $7.13/Share in Cash
The Deal: IBM (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) announced Thursday, that it plans to acquire Merge Healthcare (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) for 7.13 per share in cash, for a total transaction value of $1 billion. The deal is expected to close later this year. 
Merge closed at $7.10 on Thursday, a gain of 31%.
Mesa Labs Acquires Dental Sterilizer Testing Business for $11.25M
The Deal: Mesa Laboratories, Inc. (NASDAQ: <a class="ticker" href="/stock/mlab#NASDAQ">MLAB</a>) announced Thursday, the acquisition of substantially all of the assets and certain liabilities of the dental sterilizer testing business of North Bay Bioscience, LLC. for $11,250,000 in cash.
Mesa Labs closed at $119.57 Thursday, a gain of 1%.
Coca-Cola Enterprises Merges With Coca-Cola Iberian Partners, Coca-Cola Erfrischungsgetränke AG
The Deal: Coca-Cola Enterprises, Inc. (NYSE: <a class="ticker" href="/stock/cce#NYSE">CCE</a>), Coca-Cola Iberian Partners SA and Coca-Cola Erfrischungsgetränke AG , a wholly owned subsidiary of The Coca-Cola Company (NYSE: <a class="ticker" href="/stock/ko#NYSE">KO</a>), announced Thursday, that they have agreed to combine their businesses into a new company to be called Coca-Cola European Partners Plc. The new company will become the world's largest independent Coca-Cola bottler based on net revenues.
Coca-Cola Enterprises closed at $53.39 Thursday, a gain of almost 3%.

Rumors

MLAB

Benzinga's M&A Chatter for Thursday August 6, 2015

The Dow Jones Industrial Index declined 0.86 percent, the S&amp;P 500 dwindled 1.03 percent, the NASDAQ Composite was reduced 1.85 percent, crude oil WTI was hit 1.77 percent and the US Dollar Index was down 0.05 percent at Thursday&rsquo;s mid-day session.

	China&rsquo;s Shanghai Stock Exchange Composite Index declined 0.89 percent Thursday, while the Athens Stock Exchange General Index soared 2.95 percent.

	The nation is awaiting the Labor Department&rsquo;s July employment report on Friday, which will hint a stronger indicator on the decision to raise or keep interest rates stagnant. The Bank of England has signaled that it will remain to start raising their interest rates gently in the United Kingdom early 2016; while the British Pound continued to extend losses against the United States Dollar. The Pound Sterling declined 0.6 percent lower than the U.S. dollar and the Euro.

	Fannie Mae is to send U.S. Treasury Department a total of $4.4 billion in the month of September as an expected interest rate increase helped wheel-in a 27 percent increase in second quarter earnings; $4.64 billion in Q2 versus $3.67 billion in Q2 of 2014.

	Keurig Green Mountain Inc (NASDAQ: <a class="ticker" href="/stock/gmcr#NASDAQ">GMCR</a>) fell nearly 30 percent after the specialty coffee-maker lowered its earnings outlook for 2015 and reported slow growth on its coffee pods along with its brewing system.

	Michael Kors Holdings Inc (NYSE: <a class="ticker" href="/stock/kors#NYSE">KORS</a>) soared 12 percent as the clothing retailer topped expectations, though profits fell two consecutive quarters. Tesla Motors Inc (NASDAQ: <a class="ticker" href="/stock/tsla#NASDAQ">TSLA</a>) tumbled 11 percent after the car producer nearly tripled its losses from a year earlier, which questions if the company can become and sustain profitable.

	Bill Ackman revealed a $5.5 billion stake in Mondelez International Inc (NASDAQ: <a class="ticker" href="/stock/mdlz#NASDAQ">MDLZ</a>), specifying that he believes the company must grow revenues quickly and reduce costs &ldquo;significantly,&rdquo;or sell to a rival, according to the Wall Street Journal.
<h3>
	Winners</h3>

	Ikanos Communications, Inc. (NASDAQ: <a class="ticker" href="/stock/ikan#NASDAQ">IKAN</a>) skyrocketed 54 percent after the advanced semiconductor provider was reported to be acquired by QUALCOMM, Inc. (NASDAQ: <a class="ticker" href="/stock/qcom#NASDAQ">QCOM</a>) for $2.75 per share.

	Merge Healthcare Inc. (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) soared 31 percent after the software solutions developer was reported to be acquired by International Business Machines Corp (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) for $1 billion.

	EnerNOC, Inc. (NASDAQ: <a class="ticker" href="/stock/enoc#NASDAQ">ENOC</a>) was lifted 22 percent after the energy intelligence software (EIS) provider reported Q2 earnings of ($0.32) per share, $0.54 above analyst expectations and had sales of $72.5 million, representing a 64.6 percent year-over-year increase.

	Hortonworks Inc (NASDAQ: <a class="ticker" href="/stock/hdp#NASDAQ">HDP</a>) rose 18 percent after the enterprise-grade Hadoop solutions distributor reported Q2 adjusted loss of $0.80 per share, $0.04 ahead of analyst projections, and far less than the $5.26 per share loss in Q2 of 2014.

	NN, Inc. (NASDAQ: <a class="ticker" href="/stock/nnbr#NASDAQ">NNBR</a>) was up 16 percent after the manufacturer of metal beating, plastic, rubber, and precision metal components reported Q2 results, with sales of $164.9 million.
<h3>
	Losers</h3>

	Infosonics Corporation (NASDAQ: <a class="ticker" href="/stock/ifon#NASDAQ">IFON</a>) sunk 54 percent after the wireless handsets, tablets, and accessories provider reported Q2 results. The company concluded that gross profit margin was significantly down and operating expenses were heightened.

	Shutterstock Inc (NYSE: <a class="ticker" href="/stock/sstk#NYSE">SSTK</a>) declined 32 percent after the global marketplace operator reported Q2 net income of $5.3 million on $104.4 million in sales. Analysts were expecting revenues of $105.6 million, and Shutterstock previously announced it had expected sales of $105-$108 million for the quarter.

	Approach Resources Inc (NASDAQ: <a class="ticker" href="/stock/arex#NASDAQ">AREX</a>) was down 24 percent after the independent energy company announced Q2 sales of $38.6 million and a loss of $0.07 per share. Analysts were expecting sales of $44.46 million.

	Summer Infant, Inc.&nbsp;(NASDAQ: <a class="ticker" href="/stock/sumr#NASDAQ">SUMR</a>) dwindled 27 percent after the marketer, designer, and distributor of juvenile health reported Q2 net sales of $51.8 million, lower than Q1 sales of $52.6 million due to lower sales of licensed, private label, and furniture non-core businesses.

	Marin Software Incorporated (NYSE: <a class="ticker" href="/stock/mrin#NYSE">MRIN</a>) was down 27 percent after the provider of a cross-channel advertising cloud platform reported Q2 sales of $26.77 million, below the projected $26.99.

AREX

BZSUM

ENOC

GMCR

IFON

IKAN

KORS

MDLZ

MRIN

NNBR

QCOM

SSTK

SUMR

TSLA

Mid-Day Market Update: Thursday's Movers, Jobs Report, Bill Ackman And More

Mondelez International Inc (NASDAQ: <a class="ticker" href="/stock/mdlz#NASDAQ">MDLZ</a>) shares reached a new 52-week high of $47 as Bill Ackman disclosed a $5.5 billion stake in Mondelez. 
 Merge Healthcare Inc. (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) shares touched a new 52-week high of $7.06 after International Business Machines Corp. (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) announced its plans to buy Merge Healthcare in a $1 billion deal.
 Alaska Air Group, Inc. (NYSE: <a class="ticker" href="/stock/alk#NYSE">ALK</a>) shares rose 1.08 percent to reach a new 52-week high of $79.88 after the company announced a $1 billion share repurchase program.
 Coca-Cola Enterprises Inc (NYSE: <a class="ticker" href="/stock/cce#NYSE">CCE</a>) shares gained 2.43 percent to touch a new 52-week high of $53.10 following the announcement of merger with Coca-Cola Iberian Partners SA and Coca-Cola Erfrischungsgetränke AG.

Stocks Hitting 52-Week Highs

Merge Healthcare Shares +30% Following Announcement of Acqusition by IBM for $7.13/Share in Cash

Merge Healthcare to Resumes Trading at 9:50 AM ET

"Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash"

IBM Deal For Merge To Be Done At $7.13 In Cash

IBM (NYSE: <a class="ticker" href="/stock/ibm#NYSE">IBM</a>) today 
announced that Watson will gain the ability to "see" by bringing together 
Watson's advanced image analytics and cognitive capabilities with data and 
images obtained from Merge Healthcare Incorporated's (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) medical 
imaging management platform. IBM plans to acquire Merge, a leading provider 
of medical image handling and processing, interoperability and clinical 
systems designed to advance healthcare quality and efficiency, in an effort 
to unlock the value of medical images to help physicians make better patient 
care decisions. 
 Merge's technology platforms are used at more than 7,500 U.S. healthcare 
sites, as well as most of the world's leading clinical research institutes 
and pharmaceutical firms to manage a growing body of medical images. The 
vision is that these organizations could use the Watson Health Cloud to 
surface new insights from a consolidated, patient-centric view of current 
and historical images, electronic health records, data from wearable devices 
and other related medical data, in a HIPAA-enabled environment. 
 Under terms of the transaction, Merge shareholders would receive $7.13 per 
share in cash, for a total transaction value of $1 billion. The closing of 
the transaction is subject to regulatory review, Merge shareholder approval, 
and other customary closing conditions, and is anticipated to occur later 
this year. It is IBM's third major health-related acquisition -- and the 
largest -- since launching its Watson Health unit in April, following Phytel 
(population health) and Explorys (cloud based healthcare intelligence). 
 "As a proven leader in delivering healthcare solutions for over 20 years, 
Merge is a tremendous addition to the Watson Health platform. Healthcare 
will be one of IBM's biggest growth areas over the next 10 years, which is 
why we are making a major investment to drive industry transformation and 
to facilitate a higher quality of care," said John Kelly, senior vice 
president, IBM Research and Solutions Portfolio. "Watson's powerful 
cognitive and analytic capabilities, coupled with those from Merge and our 
other major strategic acquisitions, position IBM to partner with healthcare 
providers, research institutions, biomedical companies, insurers and other 
organizations committed to changing the very nature of health and healthcare 
in the 21(st) century. Giving Watson 'eyes' on medical images unlocks 
entirely new possibilities for the industry." 
 Teaching Watson to "See" Medical Images 
 The planned acquisition bolsters IBM's strategy to add rich image analytics 
with deep learning to the Watson Health platform -- in effect, advancing 
Watson beyond natural language and giving it the ability to "see." Medical 
images are by far the largest and fastest-growing data source in the 
healthcare industry and perhaps the world -- IBM researchers estimate that 
they account for at least 90% of all medical data today -- but they also 
present challenges that need to be addressed: 
 -- The volume of medical images can be overwhelming to even the most 
 sophisticated specialists -- radiologists in some hospital emergency 
 rooms are presented with as many as 100,000 images a day1.
 -- Tools to help clinicians extract insights from medical images remain 
very 
 limited, requiring most analysis to be done manually.
 -- At a time when the most powerful insights come at the intersection of 
 diverse data sets (medical records, lab tests, genomics, etc.), medical 
 images remain largely disconnected from mainstream health information. 
 IBM plans to leverage the Watson Health Cloud to analyze and cross-reference 
medical images against a deep trove of lab results, electronic health 
records, genomic tests, clinical studies and other health-related data 
sources, already representing 315 billion data points and 90 million unique 
records. Merge's clients could compare new medical images with a patient's 
image history as well as populations of similar patients to detect changes 
and anomalies. Insights generated by Watson could then help healthcare 
providers in fields including radiology, cardiology, orthopedics and 
ophthalmology to pursue more personalized approaches to diagnosis, treatment 
and monitoring of patients. 
 Cutting-edge image analytics projects underway in IBM Research's global labs 
suggest additional areas where progress can be made. They include teaching 
Watson to filter clinical and diagnostic imaging information to help 
clinicians identify anomalies and form recommendations, which could help 
reduce physician viewing loads and increase physician effectiveness. 
 "As Watson evolves, we are tackling more complex and meaningful problems by 
constantly evaluating bigger and more challenging data sets," Kelly said. 
"Medical images are some of the most complicated data sets imaginable, and 
there is perhaps no more important area in which researchers can apply 
machine learning and cognitive computing. That's the real promise of 
cognitive computing and its artificial intelligence components -- helping to 
make us healthier and to improve the quality of our lives." 
 Watson Health and Merge Capabilities 
 Will Benefit Researchers, Clinicians and Individuals 
 IBM's Watson Health unit plans to bring together Merge's product and 
solution offerings with existing expertise in cognitive computing, 
population health, and cloud-based healthcare intelligence offerings to: 
 -- Offer researchers insights to aid clinical trial design, monitoring and 
 evaluation;
 -- Help clinicians to efficiently identify options for the diagnosis, 
 treatment and monitoring a broad array of health conditions such as 
 cancer, stroke and heart disease;
 -- Enable providers and payers to integrate and optimize patient engagement
 in alignment with meaningful use and value-based care guidelines; and
 -- Support researchers and healthcare professionals as they advance the 
 emerging discipline of population health, which aims to optimize an 
 individual's care by identifying trends in large numbers of people with 
 similar health status. 
 "Merge is widely recognized for delivering market leading imaging workflow 
and electronic data capture solutions," said Justin Dearborn, chief 
executive officer, Merge. "Today's announcement is an exciting step forward 
for our employees and clients. Becoming a part of IBM will allow us to 
expand our global scale and deliver added value and insight to our clients 
through Watson's advanced analytic and cognitive computing capabilities." 
 "Combining Merge's leading medical imaging solutions with the world-class 
machine learning and analytics capabilities of IBM's Watson Health is the 
future of healthcare technology," said Michael W. Ferro, Jr., Merge's 
chairman. "Merge's leading technology and proven expertise represent a 
unique combination of assets that will deliver unparalleled value to Watson 
Health clients. Together, we will unlock unprecedented new opportunities to 
improve patient diagnostics and deliver enhanced care."

Watson To Acquire Merge Healthcare For $1B

Merge Healthcare Shares Halted News Pending

Inotek Pharmaceuticals Corp (NASDAQ: <a class="ticker" href="/stock/itek#NASDAQ">ITEK</a>) shares jumped 59.18 percent to $8.32 after the company reported positive End-of-Phase 2 meeting with the FDA and Phase 3 development strategy for trabodenoson, a novel treatment for glaucoma. 
Flotek Industries Inc (NYSE: <a class="ticker" href="/stock/ftk#NYSE">FTK</a>) surged 31.82 percent to $16.86 on Q2 results. Flotek Industries reported a Q2 loss of $12.5 million.
Ultra Clean Holdings Inc (NASDAQ: <a class="ticker" href="/stock/uctt#NASDAQ">UCTT</a>) shares gained 29.87 percent to $6.99 after the company reported upbeat Q2 results.
GulfMark Offshore, Inc. (NYSE: <a class="ticker" href="/stock/glf#NYSE">GLF</a>) jumped 19.91 percent to $10.24. Gulfmark Offshore reported a Q2 loss of $0.27 per share on revenue of $74.5 million.
Altisource Portfolio Solutions S.A. (NASDAQ: <a class="ticker" href="/stock/asps#NASDAQ">ASPS</a>) rose 19.58 percent to $37.00 after the company reported Q2 results and announced its plans to acquire CastleLine Holdings.
Cara Therapeutics Inc (NASDAQ: <a class="ticker" href="/stock/cara#NASDAQ">CARA</a>) surged 18.24 percent to $18.73 after the company reported positive results from Phase 2 trial in uremic pruritus.
 SanDisk Corporation (NASDAQ: <a class="ticker" href="/stock/sndk#NASDAQ">SNDK</a>) shares climbed 16.09 percent to $62.90 after the company reported stronger-than-expected results for the second quarter. 
 Merge Healthcare Inc. (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) shares climbed 13.59 percent to $5.72 on better-than-expected Q2 results.
 Cirrus Logic, Inc. (NASDAQ: <a class="ticker" href="/stock/crus#NASDAQ">CRUS</a>) jumped 11.46 percent to $34.23 after the company reported stronger-than-expected results for the second quarter.
 Fortinet Inc (NASDAQ: <a class="ticker" href="/stock/ftnt#NASDAQ">FTNT</a>) shares rose 10.15 percent to $46.59 after the company reported upbeat Q2 results.

ASPS

CARA

CRUS

FTNT

ITEK

SNDK

UCTT

Morning Market Gainers

Inotek Pharmaceuticals Corp (NASDAQ: <a class="ticker" href="/stock/itek#NASDAQ">ITEK</a>) shares rose 16.44 percent to $6.09 in pre-market trading after the company reported positive End-of-Phase 2 meeting with the FDA and Phase 3 development strategy for trabodenoson, a novel treatment for glaucoma. 
 SanDisk Corporation (NASDAQ: <a class="ticker" href="/stock/sndk#NASDAQ">SNDK</a>) shares rose 13.40 percent to $61.44 in pre-market trading after the company reported stronger-than-expected results for the second quarter. 
 Fortinet Inc (NASDAQ: <a class="ticker" href="/stock/ftnt#NASDAQ">FTNT</a>) shares climbed 11.11 percent to $47.00 in pre-market trading after the company reported upbeat Q2 results.
 Cirrus Logic, Inc. (NASDAQ: <a class="ticker" href="/stock/crus#NASDAQ">CRUS</a>) gained 10.55 percent to $33.95 in pre-market trading after the company reported stronger-than-expected results for the second quarter.
 Merge Healthcare Inc. (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) shares climbed 9.33 percent to $5.51 in pre-market trading on better-than-expected Q2 results.

Pre-Market Outlook

Benzinga's Top #PreMarket Gainers

Earnings

Merge Healthcare Reports Q2 Adj. EPS $0.09 vs $0.06 Est., Sales $65.6M vs $64M Est.

Dougherty &amp; Company initiates coverage on Merge Healthcare (NASDAQ: <a class="ticker" href="/stock/mrge#NASDAQ">MRGE</a>) with a Buy rating and a $6.00 price target.-market sources

Dougherty &amp; Company Initiates Coverage on Merge Healthcare at Buy, Announces $6.00 PT

Mirage Energy

Comments

Mirage Energy

Mirage Energy (MRGE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga